A detailed history of Stonebridge Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Stonebridge Capital Advisors LLC holds 26,627 shares of PFE stock, worth $712,005. This represents 0.06% of its overall portfolio holdings.

Number of Shares
26,627
Previous 28,943 8.0%
Holding current value
$712,005
Previous $809,000 4.82%
% of portfolio
0.06%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $64,153 - $72,699
-2,316 Reduced 8.0%
26,627 $770,000
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $59,537 - $69,767
2,357 Added 8.87%
28,943 $809,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $179,184 - $205,761
6,921 Added 35.19%
26,586 $737,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $54,663 - $71,002
-2,092 Reduced 9.62%
19,665 $566,000
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $26,987 - $31,545
-841 Reduced 3.72%
21,757 $721,000
Q2 2023

Aug 23, 2023

BUY
$36.12 - $41.79 $32,435 - $37,527
898 Added 4.14%
22,598 $828,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $10,241 - $13,332
260 Added 1.21%
21,700 $885,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $4,216 - $5,504
-101 Reduced 0.47%
21,440 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $13,128 - $16,026
300 Added 1.41%
21,541 $943,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $41,830 - $49,597
-899 Reduced 4.06%
21,241 $1.11 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $129,381 - $160,319
-2,828 Reduced 11.33%
22,140 $1.15 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $53,302 - $79,012
1,290 Added 5.45%
24,968 $1.47 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $902 - $1,159
23 Added 0.1%
23,678 $1.02 Million
Q2 2021

Aug 20, 2021

SELL
$35.91 - $40.68 $10,952 - $12,407
-305 Reduced 1.27%
23,655 $926,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $33,657 - $37,958
-1,005 Reduced 4.03%
23,960 $868,000
Q4 2020

Mar 05, 2021

BUY
$33.47 - $42.56 $36,950 - $46,986
1,104 Added 4.63%
24,965 $919,000
Q3 2020

Nov 18, 2020

BUY
$31.75 - $37.25 $19,399 - $22,759
611 Added 2.63%
23,861 $876,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $15,843 - $19,220
-526 Reduced 2.21%
23,250 $760,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $44,383 - $63,414
-1,642 Reduced 6.46%
23,776 $776,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $18,435 - $20,921
560 Added 2.25%
25,418 $996,000
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $21,410 - $27,763
659 Added 2.72%
24,858 $893,000
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $10,613 - $11,916
287 Added 1.2%
24,199 $1.05 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $38,925 - $42,765
1,038 Added 4.54%
23,912 $1.02 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $17,734 - $20,219
-461 Reduced 1.98%
22,874 $998,000
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $9,597 - $10,231
-291 Reduced 1.23%
23,335 $847,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $30,729 - $35,650
963 Added 4.25%
23,626 $839,000
Q4 2017

Feb 15, 2018

SELL
$33.26 - $35.29 $1.18 Million - $1.25 Million
-35,334 Reduced 60.92%
22,663 $821,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $13,423 - $14,786
433 Added 0.75%
57,997 $2.07 Million
Q2 2017

Aug 15, 2017

BUY
N/A
57,564
57,564 $1.93 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.